• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

PRODUCT FILTERS

REGION

1,142
109
76
71
69

COUNTRY

70
22
16
10
9

CATEGORIES

  • 575
  • 121
  • 550
  • 75
  • 526
  • 43
  • 505
  • 18
  • 18
  • 23

PRICE

1,047
1,237
1,988
3,000

PUBLISHED

26
211
644
3,000

PRODUCT TYPE

2,427
494
69
7
1
1
1

Oncology

The American Cancer Society forecasts that 1,638,910 new cancer cases will occur in the United States in 2012. As cancer rates worldwide are increasing, the oncological sector of the pharmaceutical industry is growing fast and it will continue to provide business opportunities in the next years. However, cancer trials are some of the most complex, time consuming and expensive across all therapeutic areas. What are the new paths to success in this lucrative but challenging market?

Find out the answer in the reports, books, and subscriptions listed under Research and Markets’ Oncology category. Our top-quality publications from industry experts cover every aspect of cancer drug therapy, with a focus on: Lung Cancer, Breast Cancer, Prostate Cancer, Leukaemia, Lymphoma, Ovarian Cancer, Colon Cancer, Cervical Cancer, Brain Cancer and Bladder Cancer. So read on for the latest clinical trials, pipeline reviews, industry news, and commercial opportunities.

Key players featured in our publications include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis, Wyeth, and many more. Show Less
Read more

PRODUCT TITLE

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014

Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014 Summary This, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2014’,...

August 2014
FROM

Cervical Cancer - Pipeline Review, H2 2014

Cervical Cancer - Pipeline Review, H2 2014 Summary This, ‘Cervical Cancer - Pipeline Review, H2 2014’, provides an overview of the Cervical Cancer’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023

EpiCast Report: Renal Cell Carcinoma - Epidemiology Forecast to 2023 Summary Renal cell carcinoma (RCC) is a type of kidney cancer that originates in the lining of the proximal convoluted tubule,...

August 2014
FROM

Colon Carcinoma - Pipeline Review, H2 2014

Colon Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Colon Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Colon Carcinoma’s therapeutic pipeline. This report provides comprehensive...

August 2014
FROM

Chemotherapy Induced Anemia - Pipeline Review, H2 2014

Chemotherapy Induced Anemia - Pipeline Review, H2 2014 Summary This, ‘Chemotherapy Induced Anemia - Pipeline Review, H2 2014’, provides an overview of the Chemotherapy Induced Anemia’s therapeutic...

August 2014
FROM

OpportunityAnalyzer: Non-Hodgkin's B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018

OpportunityAnalyzer: Non-Hodgkin’s B-Cell Lymphoma - Opportunity Analysis and Forecast to 2018 Summary The competitive landscape in the B-cell NHL markets in the US, France, Italy, Germany, Spain...

August 2014
FROM

Glioblastoma Multiforme Therapeutics in Asia-Pacific Markets to 2020 - Novel Therapeutic Approaches Target High Unmet Need in Newly Diagnosed and Recurrent GBM

This report provides in-depth analysis of the Glioblastoma Multiforme (GBM) therapeutics market within the Asia-Pacific (APAC) region, covering Australia, China, India and Japan. The report provides...

August 2014
FROM

Global Cancer Generics Market Outlook 2018

With the advent of novel and innovative technologies, industries like healthcare and pharmaceutical are scaling newer heights. One such market is the oncology market. With global cancer incidences rising...

August 2014
FROM
The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition - Product Thumbnail Image

The Worldwide Market for In Vitro Diagnostic Tests, 9th Edition

This single volume covers the entirety of the clinical testing market and all of its segments, providing customers with a tremendous value. Used by Top IVD Companies For Business Planning. This...

August 2014
FROM
Global Breast Cancer Market Report: 2014 Edition Global Breast Cancer Market Report: 2014 Edition - Product Thumbnail Image

Global Breast Cancer Market Report: 2014 Edition

Breast cancer is the most frequently diagnosed cancer and the leading cause of cancer death in women. Breast cancer knows no boundaries be it age, gender, socioeconomic status or geographic location....

August 2014
FROM

T-Cell Leukemia - Pipeline Review, H2 2014

T-Cell Leukemia - Pipeline Review, H2 2014 Summary This, ‘T-Cell Leukemia - Pipeline Review, H2 2014’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014

Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014 Summary This, ‘Neuro Endocrine (Carcinoid) Carcinoma - Pipeline Review, H2 2014’, provides an overview of the Neuro Endocrine (Carcinoid)...

July 2014
FROM

Rectal Cancer - Pipeline Review, H2 2014

Rectal Cancer - Pipeline Review, H2 2014 Summary This, ‘Rectal Cancer - Pipeline Review, H2 2014’, provides an overview of the Rectal Cancer’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Medullary Thyroid Cancer - Pipeline Review, H2 2014

Medullary Thyroid Cancer - Pipeline Review, H2 2014 Summary This, ‘Medullary Thyroid Cancer - Pipeline Review, H2 2014’, provides an overview of the Medullary Thyroid Cancer’s therapeutic pipeline. This...

July 2014
FROM

Medulloblastoma - Pipeline Review, H2 2014

Medulloblastoma - Pipeline Review, H2 2014 Summary This, ‘Medulloblastoma - Pipeline Review, H2 2014’, provides an overview of the Medulloblastoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Ewing Sarcoma - Pipeline Review, H2 2014

Ewing Sarcoma - Pipeline Review, H2 2014 Summary This, ‘Ewing Sarcoma - Pipeline Review, H2 2014’, provides an overview of the Ewing Sarcoma’s therapeutic pipeline. This report provides comprehensive...

July 2014
FROM

Metastatic Liver Cancer - Pipeline Review, H2 2014

Metastatic Liver Cancer - Pipeline Review, H2 2014 Summary This, ‘Metastatic Liver Cancer - Pipeline Review, H2 2014’, provides an overview of the Metastatic Liver Cancer’s therapeutic pipeline. This...

July 2014
FROM

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014

Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014 Summary This, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2014’, provides an overview of the Peripheral T-Cell Lymphomas...

July 2014
FROM

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014

Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014 Summary This, ‘Opioid-Induced Constipation (OIC) - Pipeline Review, H2 2014’, provides an overview of the Opioid-Induced Constipation (OIC)’s...

July 2014
FROM

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014

Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014 Summary This, ‘Squamous Non-Small Cell Lung Cancer - Pipeline Review, H2 2014’, provides an overview of the Squamous Non-Small Cell Lung...

July 2014
FROM
Loading Indicator

Our Clients

Our clients' logos